Singular Genomics Systems, Inc. (OMIC)
Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price
on Feb 20, 2025
Singular Genomics Systems Revenue
Singular Genomics Systems had revenue of $406.00K in the quarter ending September 30, 2024, a decrease of -12.12%. This brings the company's revenue in the last twelve months to $2.67M, up 2.77% year-over-year. In the year 2023, Singular Genomics Systems had annual revenue of $2.91M with 280.52% growth.
Revenue (ttm)
$2.67M
Revenue Growth
+2.77%
P/S Ratio
18.63
Revenue / Employee
$10,459
Employees
255
Market Cap
50.70M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.91M | 2.15M | 280.52% |
Dec 31, 2022 | 765.00K | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOMIC News
- 5 weeks ago - Singular Genomics Announces Closing of Acquisition by Deerfield Management - GlobeNewsWire
- 2 months ago - Investors With Losses Are Invited To Join The Schall Law Firm In An Investigation Into Singular Genomics Systems, Inc. For Securities Fraud - Accesswire
- 2 months ago - Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud - Accesswire
- 2 months ago - OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm - PRNewsWire
- 2 months ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud - Accesswire
- 2 months ago - SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC - Business Wire
- 3 months ago - Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share - GlobeNewsWire
- 6 months ago - Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital - GlobeNewsWire